Hydrocodone Bitartrate; Ibuprofen Patent Expiration
Hydrocodone Bitartrate; Ibuprofen was first introduced by Abbvie Inc
Hydrocodone Bitartrate; Ibuprofen Patents
Given below is the list of patents protecting Hydrocodone Bitartrate; Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vicoprofen | US6348216 | Ibuprofen and narcotic analgesic compositions |
Jun 10, 2017
(Expired) | Abbvie |
| Vicoprofen | US6599531 | Method of making ibuprofen and narcotic analgesic compositions |
Jun 10, 2017
(Expired) | Abbvie |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Hydrocodone Bitartrate; Ibuprofen's patents.
Latest Legal Activities on Hydrocodone Bitartrate; Ibuprofen's Patents
Given below is the list recent legal activities going on the following patents of Hydrocodone Bitartrate; Ibuprofen.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| File Marked Found | 19 Feb, 2016 | US6599531 |
| Correspondence Address Change Critical | 05 Sep, 2007 | US6599531 |
| Recordation of Patent Grant Mailed Critical | 29 Jul, 2003 | US6599531 |
| Patent Issue Date Used in PTA Calculation Critical | 29 Jul, 2003 | US6599531 |
| Issue Notification Mailed Critical | 10 Jul, 2003 | US6599531 |
| Receipt into Pubs | 23 Jun, 2003 | US6599531 |
| Application Is Considered Ready for Issue Critical | 18 Jun, 2003 | US6599531 |
| Receipt into Pubs | 16 Jun, 2003 | US6599531 |
| Workflow - File Sent to Contractor | 02 Apr, 2003 | US6599531 |
| Receipt into Pubs | 28 Mar, 2003 | US6599531 |
Hydrocodone Bitartrate; Ibuprofen's Family Patents
Explore Our Curated Drug Screens
Hydrocodone Bitartrate; Ibuprofen Generic API Manufacturers
Several generic applications have been filed for Hydrocodone Bitartrate; Ibuprofen. The first generic version for Hydrocodone Bitartrate; Ibuprofen was by Teva Pharmaceuticals Usa Inc and was approved on Apr 11, 2003. And the latest generic version is by Aurolife Pharma Llc and was approved on Jun 2, 2016.
Given below is the list of companies who have filed for Hydrocodone Bitartrate; Ibuprofen generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 1 generic for Hydrocodone Bitartrate; Ibuprofen. This 7.5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 200MG | tablet | Prescription | ORAL | AB | Dec 31, 2003 |
2. AMNEAL PHARMS NY
Amneal Pharmaceuticals Ny Llc has filed for 4 different strengths of generic version for Hydrocodone Bitartrate; Ibuprofen. Out of these 5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN, 7.5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN, 2.5mg;200mg version comes by the name REPREXAIN, 10mg;200mg version comes by the name REPREXAIN. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG; 200MG | tablet | Prescription | ORAL | AB | Mar 18, 2004 |
| 7.5MG; 200MG
(reference standard) | tablet | Prescription | ORAL | AB | Oct 12, 2004 |
| 2.5MG; 200MG | tablet | Discontinued | ORAL | N/A | Oct 19, 2007 |
| 10MG; 200MG | tablet | Discontinued | ORAL | N/A | Oct 19, 2007 |
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 1 generic for Hydrocodone Bitartrate; Ibuprofen. This 5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG; 200MG | tablet | Discontinued | ORAL | N/A | Jun 23, 2010 |
4. AUROLIFE PHARMA LLC
Aurolife Pharma Llc has filed for 1 generic for Hydrocodone Bitartrate; Ibuprofen. This 7.5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Aurolife Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 200MG | tablet | Prescription | ORAL | AB | Jun 2, 2016 |
Manufacturing Plant Locations New
Aurolife Pharma Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurolife Pharma Llc as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. NOSTRUM LABS INC
Nostrum Laboratories Inc has filed for 3 different strengths of generic version for Hydrocodone Bitartrate; Ibuprofen. Out of these 7.5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN, 10mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN, 5mg;200mg version comes by the name HYDROCODONE. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 200MG | tablet | Prescription | ORAL | AB | Nov 6, 2006 |
| 10MG; 200MG | tablet | Prescription | ORAL | N/A | Nov 6, 2006 |
| 5MG; 200MG | tablet | Prescription | ORAL | AB | Nov 6, 2006 |
6. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Hydrocodone Bitartrate; Ibuprofen. All of these versions come by the name HYDROCODONE BITARTRATE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 200MG | tablet | Discontinued | ORAL | N/A | May 28, 2013 |
| 5MG; 200MG | tablet | Discontinued | ORAL | N/A | May 28, 2013 |
| 10MG; 200MG | tablet | Discontinued | ORAL | N/A | May 28, 2013 |
| 2.5MG; 200MG | tablet | Discontinued | ORAL | N/A | May 28, 2013 |
7. TEVA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Hydrocodone Bitartrate; Ibuprofen. This 7.5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG; 200MG | tablet | Discontinued | ORAL | N/A | Apr 11, 2003 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||
8. VINTAGE PHARMS
Vintage Pharmaceuticals Inc has filed for 1 generic for Hydrocodone Bitartrate; Ibuprofen. This 5mg;200mg version comes by the name HYDROCODONE BITARTRATE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Vintage Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG; 200MG | tablet | Prescription | ORAL | AB | Nov 6, 2006 |